Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,586 GBX | -0.22% | -2.52% | +9.50% |
Apr. 17 | GSK Reports Positive Data for Gonorrhea Treatment Gepotidacin, Shingles Vaccine Shingrix | MT |
Apr. 17 | GSK: positive clinical results for gonorrhea | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.50% | 80.88B | |
+28.79% | 676B | |
+24.84% | 554B | |
-7.64% | 349B | |
+15.00% | 318B | |
+5.99% | 291B | |
+3.36% | 210B | |
-0.15% | 204B | |
-9.61% | 194B | |
-11.71% | 144B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Gavi to Fund Supply of GlaxoSmithKline's Malaria Vaccine to Children in Africa